Induction of potent antitumor immunity by in situ targeting of intratumoral DCs
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Nonstandard abbreviations used: antigen (Ag); bone marrow (BM); CG-rich motif (CpG); complete medium (CM); control oligonucleotide (ODN-CTR); effector/target (E/T); Fms-like thyrosine kinase 3 ligand (Flt3L); Langerhans cell (LC); macrophage inflammatory protein-3α (MIP-3α); mean fluorescence intensity (MFI); T cell receptor (TCR).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“A preclinical murine melanoma model showed increased migration of DCs in CCL20‐positive tumor cells, indicating the role of CCL20 in attracting DCs to the tumor site [368].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [368]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336
Immunobiology of Dendritic Cells
Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y.-J., Pulendran, B., & Palucka, K. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.767 · Cited by 6,634
T cell receptor antagonist peptides induce positive selection
Hogquist, K. A., Jameson, S. C., Heath, W. R., Howard, J. L., Bevan, M. J., & Carbone, F. R. (1994) · Cell · doi:10.1016/0092-8674(94)90169-4 · Cited by 2,858
Gabrilovich, D. I., Chen, H. L., Girgis, K. R., Cunningham, H. T., Meny, G. M., Nadaf, S., Kavanaugh, D., & Carbone, D. P. (1996) · Nature Medicine · doi:10.1038/nm1096-1096 · Cited by 1,977
REGULATION OF IMMUNE RESPONSES BY TGF-β
Letterio, J. J., & Roberts, A. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.137 · Cited by 1,890
Dieu, M.-C., Vanbervliet, B., Vicari, A., Bridon, J.-M., Oldham, E., Aït-Yahia, S., Brière, F., Zlotnik, A., Lebecque, S., & Caux, C. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.373 · Cited by 1,425
Dhodapkar, M. V., Steinman, R. M., Krasovsky, J., Munz, C., & Bhardwaj, N. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.2.233 · Cited by 1,359
Induction of tolerance by IL-10-treated dendritic cells
Steinbrink, K., Wölfl, M., Jonuleit, H., Knop, J., & Enk, A. H. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.10.4772 · Cited by 1,246
Maraskovsky, E., Brasel, K., Teepe, M., Roux, E. R., Lyman, S. D., Shortman, K., & McKenna, H. J. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.5.1953 · Cited by 1,115
Mayordomo, J. I., Zorina, T., Storkus, W. J., Zitvogel, L., Celluzzi, C., Falo, L. D., Melief, C. J., Ildstad, S. T., Martin Kast, W., Deleo, A. B., et al. (1995) · Nature Medicine · doi:10.1038/nm1295-1297 · Cited by 1,074
Chemokines and Cell Migration in Secondary Lymphoid Organs
Cyster, J. G. (1999) · Science · doi:10.1126/science.286.5447.2098 · Cited by 1,031
Salcedo, R., Ponce, M. L., Young, H. A., Wasserman, K., Ward, J. M., Kleinman, H. K., Oppenheim, J. J., & Murphy, W. J. (2000) · Blood · doi:10.1182/blood.v96.1.34 · Cited by 859
Rahemtulla, A., Fung-Leung, W. P., Schilham, M. W., Kündig, T. M., Sambhara, S. R., Narendran, A., Arabian, A., Wakeham, A., Paige, C. J., Zinkernagel, R. M., et al. (1991) · Nature · doi:10.1038/353180a0 · Cited by 684
Dendritic Cells in Cancer Immunotherapy
Fong, L., & Engleman, E. G. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.245 · Cited by 680
Self-citationMenetrier-Caux, C., Montmain, G., Dieu, M. C., Bain, C., Favrot, M. C., Caux, C., & Blay, J. Y. (1998) · Blood · doi:10.1182/blood.v92.12.4778 · Cited by 590
Iwasaki, A., & Kelsall, B. L. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.8.1381 · Cited by 578
Bell, D., Chomarat, P., Broyles, D., Netto, G., Harb, G. M., Lebecque, S., Valladeau, J., Davoust, J., Palucka, K. A., & Banchereau, J. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.10.1417 · Cited by 544
CD8 is needed for development of cytotoxic T but not helper T cells
Fung-Leung, W.-P., Schilham, M. W., Rahemtulla, A., Kündig, T. M., Vollenweider, M., Potter, J., van Ewijk, W., & Mak, T. W. (1991) · Cell · doi:10.1016/0092-8674(91)90462-8 · Cited by 529
Identification of CCR6, the Specific Receptor for a Novel Lymphocyte-directed CC Chemokine LARC
Baba, M., Imai, T., Nishimura, M., Kakizaki, M., Takagi, S., Hieshima, K., Nomiyama, H., & Yoshie, O. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.23.14893 · Cited by 409
Liao, F., Rabin, R. L., Smith, C. S., Sharma, G., Nutman, T. B., & Farber, J. M. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.1.186 · Cited by 363
Hieshima, K., Imai, T., Opdenakker, G., Van Damme, J., Kusuda, J., Tei, H., Sakaki, Y., Takatsuki, K., Miura, R., Yoshie, O., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.9.5846 · Cited by 358
Vicari, A. P., Chiodoni, C., Vaure, C., Aït-Yahia, S., Dercamp, C., Matsos, F., Reynard, O., Taverne, C., Merle, P., Colombo, M. P., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020732 · Cited by 343
Chemokines and the Homing of Dendritic Cells to the T Cell Areas of Lymphoid Organs
Cyster, J. G. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.3.447 · Cited by 327
Dendritic cell biology and regulation of dendritic cell trafficking by chemokines
Caux, C., Ait-Yahia, S., Chemin, K., de Bouteiller, O., Dieu-Nosjean, M.-C., Homey, B., Massacrier, C., Vanbervliet, B., Zlotnik, A., & Vicari, A. (2000) · Springer Seminars in Immunopathology · doi:10.1007/s002810000053 · Cited by 313
Flt3 ligand induces tumor regression and antitumor immune responses in vivo
Lynch, D. H., Andreasen, A., Maraskovsky, E., Whitmore, J., Miller, R. E., & Schuh, J. C. L. (1997) · Nature Medicine · doi:10.1038/nm0697-625 · Cited by 308
Datta, S. K., Redecke, V., Prilliman, K. R., Takabayashi, K., Corr, M., Tallant, T., DiDonato, J., Dziarski, R., Akira, S., Schoenberger, S. P., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.8.4102 · Cited by 302
Vermi, W., Bonecchi, R., Facchetti, F., Bianchi, D., Sozzani, S., Festa, S., Berenzi, A., Cella, M., & Colonna, M. (2003) · The Journal of Pathology · doi:10.1002/path.1344 · Cited by 295
Cho, H. J., Takabayashi, K., Cheng, P.-M., Nguyen, M.-D., Corr, M., Tuck, S., & Raz, E. (2000) · Nature Biotechnology · doi:10.1038/75365 · Cited by 258
Divergent Therapeutic and Immunologic Effects of Oligodeoxynucleotides with Distinct CpG Motifs
Ballas, Z. K., Krieg, A. M., Warren, T., Rasmussen, W., Davis, H. L., Waldschmidt, M., & Weiner, G. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.9.4878 · Cited by 252
Tumour escape from immune surveillance through dendritic cell inactivation
Vicari, A. P., Caux, C., & Trinchieri, G. (2002) · Seminars in Cancer Biology · doi:10.1006/scbi.2001.0400 · Cited by 228
Kawarada, Y., Ganss, R., Garbi, N., Sacher, T., Arnold, B., & Hämmerling, G. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.9.5247 · Cited by 220
Developmental Switches in Chemokine Response Profiles during B Cell Differentiation and Maturation
Bowman, E. P., Campbell, J. J., Soler, D., Dong, Z., Manlongat, N., Picarella, D., Hardy, R. R., & Butcher, E. C. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.8.1303 · Cited by 212
Vanbervliet, B., Homey, B., Durand, I., Massacrier, C., Aït-Yahia, S., Bouteiller, O. D., Vicari, A., & Caux, C. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200201)32:1<231::aid-immu231>3.0.co;2-8 · Cited by 171
Fushimi, T., Kojima, A., Moore, M. A. S., & Crystal, R. G. (2000) · Journal of Clinical Investigation · doi:10.1172/jci7548 · Cited by 168
Sparwasser, T., Vabulas, R. M., Villmow, B., Lipford, G. B., & Wagner, H. (2000) · European Journal of Immunology · doi:10.1002/1521-4141(200012)30:12<3591::aid-immu3591>3.0.co;2-j · Cited by 165
Antitumor Effects of the Mouse Chemokine 6Ckine/SLC Through Angiostatic and Immunological Mechanisms
Vicari, A. P., Ait-Yahia, S., Chemin, K., Mueller, A., Zlotnik, A., & Caux, C. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.4.1992 · Cited by 153
Effect of flt3 ligand on the ex vivo expansion of human CD34+ hematopoietic progenitor cells
McKenna, H. J., de Vries, P., Brasel, K., Lyman, S. D., & Williams, D. E. (1995) · Blood · doi:10.1182/blood.v86.9.3413.bloodjournal8693413 · Cited by 138
Kranzer, K., Bauer, M., Lipford, G. B., Heeg, K., Wagner, H., & Lang, R. (2000) · Immunology · doi:10.1046/j.1365-2567.2000.00964.x · Cited by 115
In vivo manipulation of dendritic cells to induce therapeutic immunity
Merad, M., Sugie, T., Engleman, E. G., & Fong, L. (2002) · Blood · doi:10.1182/blood.v99.5.1676 · Cited by 109
Self-citationKucharzik, T. F., Hudson, J. T., Waikel, R. L., Martin, W. D., & Williams, I. R. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200201)32:1<104::aid-immu104>3.0.co;2-c · Cited by 104
Liao, F., Shirakawa, A., Foley, J. F., Rabin, R. L., & Farber, J. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.10.4871 · Cited by 92
Varona, R., Zaballos, A., Gutiérrez, J., Martı́n, P., Roncal, F., Albar, J. P., Ardavı́n, C., & Márquez, G. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01450-1 · Cited by 88
Cui, Y. R., Kelleher, E., Straley, E., Fuchs, E. J., Gorski, K. S., Levitsky, H. I., Borrello, I., Civin, C. I., Schoenberger, S. P., Cheng, L., et al. (2003) · Nature Medicine · doi:10.1038/nm882 · Cited by 57
Bisti, S., Konidou, G., Papageorgiou, F., Milon, G., Boelaert, J. R., & Soteriadou, K. (2000) · European Journal of Immunology · doi:10.1002/1521-4141(200012)30:12<3732::aid-immu3732>3.0.co;2-d · Cited by 40
Favre-Félix, N., Martin, M. S., Maraskovsky, E., Fromentin, A., Moutet, M., Solary, É., Martin, F., & Bonnotte, B. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000615)86:6<827::aid-ijc11>3.0.co;2-r · Cited by 27
Sunscreens and cutaneous malignant melanoma: An Italian case-control study
Naldi, L., Gallus, S., Imberti, G. L., CAINELLI, T., Negri, E., & Vecchia, C. L. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000615)86:6<888::aid-ijc21>3.0.co;2-7 · Cited by 23
Research works printed but not linked: 3
- Gabrilovich, D.I., Corak, J., Ciernik, I.F., Kavanaugh, D., and Carbone, D.P. 1997. Decreased antigen pre- sentation by dendritic cells in patients with breast cancer. Clin. Cancer Res. 3:483-490.
- Nestle, F.O., Burg, G., Fah, J., Wrone-Smith, T., and Nickoloff, B.J. 1997. Human sunlight-induced basal- cell-carcinoma-associated dendritic cells are deficient in T cell co-stimulatory molecules and are impaired as antigen-presenting cells. Am. J. Pathol. 150:641-651.
- Chen, K., et al. 1997. Antitumor activity and immunotherapeutic properties of Flt3-ligand in a murine breast cancer model. Cancer Res. 57:3511-3516.
Cited by
Munn, D. H., Sharma, M. D., Hou, D., Baban, B., Lee, J. R., Antonia, S. J., Messina, J. L., Chandler, P., Koni, P. A., & Mellor, A. L. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21583 · Cited by 852
T Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor Immunity
Martin-Orozco, N., Muranski, P., Chung, Y., Yang, X. O., Yamazaki, T., Lu, S., Hwu, P., Restifo, N. P., Overwijk, W. W., & Dong, C. (2009) · Immunity · doi:10.1016/j.immuni.2009.09.014 · Cited by 800
Key chemokines direct migration of immune cells in solid tumors
Kohli, K., Pillarisetty, V. G., & Kim, T. S. (2022) · Cancer Gene Therapy · doi:10.1038/s41417-021-00303-x · Cited by 583
Guiducci, C., Vicari, A. P., Sangaletti, S., Trinchieri, G., & Colombo, M. P. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4262 · Cited by 549
Toll-Like Receptors on Tumor Cells Facilitate Evasion of Immune Surveillance
Huang, B., Zhao, J., Li, H., He, K.-L., Chen, Y., Mayer, L., Unkeless, J. C., & Xiong, H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0784 · Cited by 542
Metadata
- Authors
- Furumoto, K., Soares, L., Engleman, E. G., & Merad, M.
- Affiliations
- Stanford Medicine (US)
- Corresponding author
- Engleman, Edgar G.
- ORCID
- Engleman, Edgar G.
- Venue
- Journal of Clinical Investigation
- Published
- 2004-03-01
- Volume
- 113
- Issue
- 5
- Pages
- 774-783
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W4238827986
- Cited by
- 180
- References
- 43
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 8 · 2023: 7 · 2022: 3 · 2021: 6 · 2020: 5 · 2019: 3 · 2018: 2 · 2017: 3 · 2016: 6 · 2015: 6 · 2014: 4 · 2013: 6 · 2012: 6
- FWCI
- 7.07
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Keywords
- antitumor immunity, dendritic cells, cancer immunotherapy, Langerhans cells, macrophage inflammatory protein-3α, Flt3 ligand, CpG oligodeoxynucleotides, T cell activation, tumor-associated macrophages
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.